v3.25.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 28, 2025
Jun. 29, 2024
Jun. 28, 2025
Jun. 29, 2024
Income Statement [Abstract]        
Net revenues $ 74,958 $ 93,185 $ 143,689 $ 168,788
Cost of goods sold 66,367 79,468 136,163 151,403
Gross profit 8,591 13,717 7,526 17,385
Research and development expenses 5,807 5,485 13,269 15,345
Selling, general and administrative expenses 37,696 42,163 85,368 89,445
Total operating expenses 43,503 47,648 98,637 104,790
Loss from operations (34,912) (33,931) (91,111) (87,405)
Other income (expense), net:        
Interest expense (2,002) (1,029) (3,026) (2,044)
Other, net 7,731 477 12,049 600
Total other income (expense), net 5,729 (552) 9,023 (1,444)
Loss before taxes (29,183) (34,483) (82,088) (88,849)
Income tax benefit 0 (34) 0 (32)
Equity in losses of unconsolidated joint venture 59 30 70 23
Net loss $ (29,242) $ (34,479) $ (82,158) $ (88,840)
Net loss per share available to common stockholders—basic (in dollars per share) $ (0.38) $ (0.53) $ (1.08) $ (1.37)
Net loss per share available to common stockholders—diluted (in dollars per share) $ (0.38) $ (0.53) $ (1.08) $ (1.37)
Weighted average common shares outstanding—basic (in shares) 76,491,594 64,901,584 76,348,524 64,797,245
Weighted average common shares outstanding—diluted (in shares) 76,491,594 64,901,584 76,348,524 64,797,245